High Content Image Analysis using a Laser Scanning Microplate Cytometer
Poster Feb 28, 2008
Paul Wylie, Ben Schenker, Sarah Payne and Andrew Goulter
Microscope-based high-content instruments offer high optical resolution, however, the limited field of view afforded by their objective lenses can mean lengthy read times for some assays, especially where multiple image capture per well is required. Wherever possible, only a small percentage of the total number of cells present in a test well are analysed to keep plate read times at a minimum, which may not always be ideal. Microplate laser- scanning cytometers, such as TTP LabTech’s Acumen® eX3, are an alternative platform. This technology offershigher throughput than imaging based systems processing 300,000 wells of data in 24 hours in 1536 plates. The Acumen eX3 is capable of generating cytometric data and TIFF images (8 or 16-bit) simultaneously. The images represent the whole well and correlate with those captured using a 20x microscope objective.The images produced can be subjected to the full range of algorithms contained in commercially available image analysis software. In most cases where image analysis and cytometric analysis have been validated, both methods were comparable where single cells were represent. For a limited number of applications, however, secondary information provided by image analysis may increase understanding. Such assays include angiogenesis, cell colony formation and tissue scanning.
Microplate cytometry offers whole well, high throughput capability with the increased flexibility of simultaneous cytometric and TIFF image outputs and presents a comprehensive solution for high content analysis studies.
Performance of the D5000 and High Sensitivity D5000 ScreenTape Assays for the 4200 TapeStation SystemPoster
Here, we focus on quantification, sizing, and sensitivity of both D5000 ScreenTape assays.READ MORE
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE